House dust mites–driven allergic rhinitis: could its natural history be modified?

References

• Mims JW. Epidemiology of allergic rhinitis. Int Forum Allergy Rhinol. 2014;4(Suppl 2):S18–20.
   PubMed Web of Science ®Google Scholar
• Han X, Krempski JW, Nadeau K. Advances and novel developments in mechanisms of allergic inflammation. Allergy. 2020;75(12):3100–3111. (in press). .
   Web of Science ®Google Scholar
• Ciprandi G, Buscaglia S, Pesce G, et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol. 1995;96:971–979.
   PubMed Web of Science ®Google Scholar
• Oppenheimer J, Slade DJ, Hahn BA, et al. Real-world evidence: patient views on asthma in respiratory specialist clinics in America. Ann Allergy Asthma Immunol. 2020 Dec 30;1081–1206(20):31279.
   Google Scholar
• Miller JD. The Role of Dust Mites in Allergy. Clin Rev Allergy Immunol. 2019;57(3):312–329.
   PubMed Web of Science ®Google Scholar
• Cao H, Liu Z. Clinical significance of dust mite allergens. Mol Biol Rep. 2020;47(8):6239–6246.
   PubMed Web of Science ®Google Scholar
• Sidenius KE, Hallas TE, Poulsen LK, et al. Allergen cross-reactivity between house-dust mites and other invertebrates. Allergy. 2001;56(8):723–733. .
   PubMed Web of Science ®Google Scholar
• Meltzer EO. Allergic rhinitis: burden of illness, quality of life, comorbidities, and control. Immunol Allergy Clin North Am. 2016;36(2):235–248. .
   PubMed Web of Science ®Google Scholar
• Gabet S, Rancière F, Just J, et al. Asthma and allergic rhinitis risk depends on house dust mite specific IgE levels in PARIS birth cohort children. World Allergy Organ J. 2019;12(9):100057.
   PubMed Web of Science ®Google Scholar
• Demoly P, Matucci A, Rossi O, et al. The disease burden in patients with respiratory allergies induced by house dust mites: a year‑long observational survey in three European countries. Clin Transl Allergy. 2020;10:27.
   PubMed Web of Science ®Google Scholar
• Gelardi M, Peroni DG, Incorvaia C, et al. Seasonal changes in nasal cytology in mite-allergic patients. J Inflamm Res. 2014;7:39–44.
   PubMedGoogle Scholar
• Ciprandi G, Cosentino C, Milanese M, et al. Fexofenadine treatment reduces nasal congestion in allergic rhinitis Allergy. Allergy. 2001;56(11):1068–1070. .
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Cirillo I, Vizzaccaro A, et al. Nasal obstruction in patients with seasonal allergic rhinitis: relationships between allergic inflammation and nasal airflow. Int Arch Allergy Immunol. 2004;134:34–40.
   PubMed Web of Science ®Google Scholar
• Rudman Spergel AK, Minnicozzi M, Wheatley LM, et al. Is Allergen Immunotherapy in Children Disease Modifying? A Review of the Evidence. Curr Allergy Asthma Rep. 2018;18(9):47. .
   PubMed Web of Science ®Google Scholar
• Yang L, Fu J, Zhou Y. Research Progress in Atopic March. Front Immunol. 2020;11:1907.
   PubMed Web of Science ®Google Scholar
• Waldman AR, Ahluwalia J, Udkoff J, et al. Atopic Dermatitis. Pediatr Rev. 2018;39(4):180–193. .
   PubMed Web of Science ®Google Scholar
• Shin JH, Lee DH. How does the pattern of aeroallergen sensitization change over time across all ages? Int Forum Allergy Rhinol. 2017 Jul;7(7):652–659.
   PubMed Web of Science ®Google Scholar
• Braunstahl GJ, Kleinjan A, Overbeek SE, et al. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med. 2000;161:2051–2057.
   PubMed Web of Science ®Google Scholar
• Braunstahl GJ, Overbeek SE, Kleinjan A, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol. 2001;107:469–476.
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Signori A, Tosca MA, et al. Spirometric abnormalities in patients with allergic rhinitis: indicator of an asthma march? Am J Rhinol Allergy. 2011;32:22–28.
   Google Scholar
• Cirillo I, Marseglia GL, Klersy C, et al. Allergic patients have more numerous and prolonged respiratory infections than non-allergic subjects. Allergy. 2007;62(9):1087–1090. .
   PubMed Web of Science ®Google Scholar
• Gabet S, Just J, Courderc R, et al. Early polysensitization is associated with allergic multimorbidity in PARIS birth cohort infants. Pediatr Allergy Immunol. 2020;31(6):722.
   PubMed Web of Science ®Google Scholar
• Yii ACA, Tay TR, Choo XN, et al. Precision medicine in united airways disease: a “treatable traits” approach. Allergy. 2018;73(10):1964–1978. .
   PubMed Web of Science ®Google Scholar
• Wise SK, Lin SY, Toskala E, et al., International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108–352. .
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Cirillo I, Pistorio A. Impact of allergic rhinitis on asthma: effects on spirometric parameters. Allergy. 2008;63(3):255–260.
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Capasso M. Association of childhood perennial allergic rhinitis with subclinical airflow limitation. Clin Exp Allergy. 2010;40:398–402.
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Cirillo I, Klersy C, et al. Role of FEF25-75 as an early marker of bronchial impairment in patients with seasonal allergic rhinitis. Am J Rhinol. 2006;20(6):641–647. .
   PubMedGoogle Scholar
• Cirillo I, Pistorio A, Tosca MA, et al. Impact of allergic rhinitis on asthma: effects on bronchial hyperreactivity. Allergy. 2009;64:439–444.
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Tosca MA, Cirillo I, et al. Impact of allergic rhinitis on asthma in children: effects on bronchial hyperreactivity. Allergy. 2010;65:1199–1201.
   PubMedGoogle Scholar
• Ciprandi G, Cirillo I, Pistorio A, et al. Impact of allergic rhinitis on asthma: effects on bronchodilation test. Ann Allergy Asthma Immunol. 2008;101:42–46.
   PubMed Web of Science ®Google Scholar
• Capasso M, Varricchio A, Ciprandi G. Impact of allergic rhinitis on asthma in children: effects on bronchodilation test. Allergy. 2010 Feb;65(2):264–268.
   PubMed Web of Science ®Google Scholar
• Cirillo I, Ricciardolo F, Medusei G, et al. Exhaled nitric oxide may predict bronchial hyperreactivity in patients with allergic rhinitis. Int Arch Allergy Immunol. 2013;160:322–328.
   PubMed Web of Science ®Google Scholar
• Huang FL, Liao EC, Yu SJ. House dust mite allergy: its innate immune response and immunotherapy. Immunobiology. 2018;223(3):300–302.
   PubMed Web of Science ®Google Scholar
• Eljaszewicz A, Ruchti F, Radzikowska U, et al. Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy. J Allergy Clin Immunol. 2020. (in press). DOI: 10.1016/j.jaci.2020.08.042.
   PubMedGoogle Scholar
• Serrano CD, Valero A, Bartra J, et al. Nasal and bronchial inflammation after nasal allergen challenge: assessment using noninvasive methods. J Investig Allergol Clin Immunol. 2012;22(5):351–356.
   PubMed Web of Science ®Google Scholar
• Huang R, Qln R, Hu Q, et al. Effect of Dermatophagoides pteronyssinus immunotherapy on upper and lower airway eosinophilic inflammatory response to nasal allergen challenge. Allergy Asthma Immunol Res. 2020;12:844–858.
   PubMed Web of Science ®Google Scholar
• Feng B, Xiang H, Jin H, et al. Efficacy of sublingual immunotherapy for house dust mite-induced allergic rhinitis: a meta-analysis of randomized controlled trials. Allergy Asthma Immunol Res. 2017 May;9(3):220–228. .
   PubMed Web of Science ®Google Scholar
• Cho SW, Han DH, Kim JW, et al. House dust mite sublingual immunotherapy in allergic rhinitis. Immunotherapy. 2018;10(7):567–578. .
   PubMed Web of Science ®Google Scholar
• Agache I, Lau S, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: house dust mite-driven allergic asthma. Allergy. 2019;74:855–873.
   PubMed Web of Science ®Google Scholar
• Nelson HS. Immunotherapy for house-dust mite allergy. Allergy Asthma Proc. 2018;39:264–272. .
   PubMed Web of Science ®Google Scholar
• Tahamiler R, Saritzali G, Canakcioglu S, et al. Comparison of the long-term efficacy of subcutaneous and sublingualimmunotherapies in perennial rhinitis. ORL J Otorhinolaryngol Relat Spec. 2008;70(3):144–150. .
   PubMedGoogle Scholar
• Chelladurain Y, Suarez-Cuervo C. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. J Allergy Clin Immunol Pract. 2013;1(4):361–369.
   PubMed Web of Science ®Google Scholar
• Durham SR, Penagos M. Sublingual or subcutaneous immunotherapy for allergic rhinitis? J Allergy Clin Immunol. 2016;137(2):339–349. e10. .
   PubMed Web of Science ®Google Scholar
• Ronborg S, Johnsen CR, Theilgaard S, et al. Cost-minimization analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark. J Med Econ. 2016;19(8):735–741.
   PubMed Web of Science ®Google Scholar
• Liu W, Zeng Q, He C, et al. Compliance, efficacy, and safety of subcutaneous and sublingual immunotherapy in children with allergic rhinitis. Pediatr Allergy Immunol. 2020. (in press). DOI: 10.1111/pai.13332.
   Web of Science ®Google Scholar
• Honeybrook A, Ellison M, Puscas L, et al. Otolaryngologist adherence to the AAO-HNSF allergic rhinitis clinical practice guideline. Int Forum Allergy Rhinol. 2018;8(6):741–750. .
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Ricca V, Ferrero P, et al. Duration of antiinflammatory and symptomatic effects after suspension of intranasal corticosteroid in persistent allergic rhinitis. Eur Ann Allergy Clin Immunol. 2004;36:63–66.
   PubMedGoogle Scholar
• Demoly P, Emminger W, Rehm D, et al. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: results from a randomized, double-blind, placebo-controlled phase III trial. J Allergy Clin Immunol. 2016;137:444–451.
   PubMed Web of Science ®Google Scholar
• Demoly P, Corren J, Creticos P, et al. A 300°IR sublingual tablet is an effective, safe treatment house-dust-mite-induced allergic rhinitis: an international, double-blind, placebo-controlled, randomized Phase III clinical trial. J Allergy Clin Immunol. 2020. (in press). 10.1016/j.jaci.2020.07.036.
   Google Scholar
• Vitiello G, Maltagliati L, Rossi O. New perspectives in allergen-specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets. Clin Mol Allergy. 2020;18: 18–10.
   PubMedGoogle Scholar
• Nolte H, Maloney J. The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases. Allergol Int. 2018;67(3):301–308.
   PubMed Web of Science ®Google Scholar
• Valovirta E, Petersen TH, Piotrowska T, et al. Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy. J Allergy Clin Immunol. 2018;141(2):529–538. e13. .
   PubMed Web of Science ®Google Scholar
• Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007;62:943–948.
   PubMed Web of Science ®Google Scholar
• Bachert C, Akdis CA. Specific allergy and asthma prevention coming to an age: a milestone in children. J Allergy Clin Immunol. 2018;141(2):527–528.
   PubMed Web of Science ®Google Scholar
• Barberi S, Bernardo L, D’Auria E, et al. Allergen immunotherapy and respiratory infections in children: an encouraging experience. Minerva Pediatr. 2018;70:1–4.
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Comite P, Bruzzone M, et al. Can pan-allergens affect the sensitization pattern? Immunobiology. 2017;222:726–729.
   PubMed Web of Science ®Google Scholar
• Valovirta E, Editer. EFA book on respiratory allergies. Brussels, Belgium: European Federation of Asthma. 2011.
   Google Scholar
• Miraglia Del Giudice M, Licari A, Brambilla I, et al. Allergen immunotherapy in pediatric asthma: a pragmatic point of view. Children (Basel). 2020;7(6):58. .
   Web of Science ®Google Scholar
• Cox LS, Murphey A, Hankin C. The cost-effectiveness of allergen immunotherapy compared with pharmacotherapy for treatment of allergic rhinitis and asthma. Immunol Allergy Clin North Am. 2020;40(1):69–85.
   PubMed Web of Science ®Google Scholar
• Gallenga CE, Pandolfi F, Caraffa A, et al. Interleukin-1 family cytokines and mast cells: activation and inhibition. J Biol Regul Homeost Agents. 2019;33(1):1–6.
   PubMed Web of Science ®Google Scholar
• Caraffa A, Gallenga CE, Kritas SK, et al. Impact of mast cells in systemic lupus erythematosus: can inflammation be inhibited? J Biol Regul Homeost Agents. 2019;33(3):669–673.
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Passali D. The management of upper airway diseases: an ongoing challenge for the clinician. J Biol Regul Homeost Agents. 2020. (in press)
   Google Scholar